Market research
PYC.LSE Physiomics Plc
LSE GBP Healthcare
Latest close
As of 30 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 0.2
- Dividend yield
- Not available
- Beta
- 1.03
Profile
Instrument facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Biotechnology
- ISIN
- GB00BDR6W943
- Market cap
- 2M
- P/E ratio
- Not available
- Analyst target
- 0.2
- Dividend yield
- Not available
- Beta
- 1.03
About
About Physiomics Plc
Physiomics Plc engages in the provision of consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Research context
Physiomics Plc appears in PyInvesting’s London Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Biotechnology
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the PYC.LSE discussion.
5 years, 6 months ago
Physiomics Plc is currently in a long term downtrend where the price is trading 8.4% below its 200 day moving average.
From a valuation standpoint, the stock is 98.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 7.1.
Physiomics Plc's total revenue sank by 0.0% to $172K since the same quarter in the previous year.
Its net income has dropped by 0.0% to $-41K since the same quarter in the previous year.
Finally, its free cash flow grew by 96.6% to $28K since the same quarter in the previous year.
Based on the above factors, Physiomics Plc gets an overall score of 2/5.